Skip to main content
. Author manuscript; available in PMC: 2017 Aug 2.
Published in final edited form as: Circulation. 2016 Aug 2;134(5):378–391. doi: 10.1161/CIRCULATIONAHA.115.019949

Figure 3. Percent Change of Primary and Secondary Endpoints Post Treatment.

Figure 3

Percent changes from baseline to post treatment of the primary and secondary endpoints are shown for the omega-3 fatty acid treated group (red bars) and placebo arm (blue bars). LVESVI denotes left ventricular end-systolic volume index, and LVEF left ventricular ejection fraction.